Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 1
1982 3
1983 3
1984 3
1985 3
1986 11
1987 11
1988 9
1989 10
1990 6
1991 8
1992 4
1993 8
1994 4
1995 2
1996 7
1997 11
1998 9
1999 9
2000 15
2001 12
2002 12
2003 13
2004 9
2005 14
2006 12
2007 9
2008 9
2009 10
2010 20
2011 25
2012 19
2013 25
2014 31
2015 33
2016 34
2017 30
2018 26
2019 27
2020 8
Text availability
Article attribute
Article type
Publication date

Search Results

486 results
Results by year
Filters applied: . Clear all
Page 1
Autism Risk and Serotonin Reuptake Inhibitors-Reply.
Janecka M, Sandin S, Reichenberg A. Janecka M, et al. JAMA Psychiatry. 2019 May 1;76(5):548-549. doi: 10.1001/jamapsychiatry.2019.0081. JAMA Psychiatry. 2019. PMID: 30840039 No abstract available.
Autism Risk and Serotonin Reuptake Inhibitors.
Anderson GM. Anderson GM. JAMA Psychiatry. 2019 May 1;76(5):547-548. doi: 10.1001/jamapsychiatry.2019.0073. JAMA Psychiatry. 2019. PMID: 30840041 No abstract available.
Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy: A Review of Current Evidence.
Alwan S, Friedman JM, Chambers C. Alwan S, et al. CNS Drugs. 2016 Jun;30(6):499-515. doi: 10.1007/s40263-016-0338-3. CNS Drugs. 2016. PMID: 27138915 Review.
Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed antidepressant medications worldwide. However, over the past decade, their use during pregnancy, a period of extreme vulnerability to the onset of depression, has become highly c …
Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed antidepressant medications worldwide. …
Obsessive-compulsive disorder in children and adolescents.
Krebs G, Heyman I. Krebs G, et al. Arch Dis Child. 2015 May;100(5):495-9. doi: 10.1136/archdischild-2014-306934. Epub 2014 Nov 14. Arch Dis Child. 2015. PMID: 25398447 Free PMC article. Review.
Issues relating to differential diagnosis are summarised, including the challenges of distinguishing OCD from autism spectrum disorders and tic disorders in youth. The recommended treatments, namely cognitive behaviour therapy and serotonin reuptake inhibitin …
Issues relating to differential diagnosis are summarised, including the challenges of distinguishing OCD from autism spectrum disorde …
Selective serotonin reuptake inhibitor use in pregnant women; pharmacogenetics, drug-drug interactions and adverse effects.
Ornoy A, Koren G. Ornoy A, et al. Expert Opin Drug Metab Toxicol. 2018 Mar;14(3):247-259. doi: 10.1080/17425255.2018.1430139. Epub 2018 Jan 24. Expert Opin Drug Metab Toxicol. 2018. PMID: 29345153 Review.
Possible negative effects of selective serotonin reuptake inhibitors (SSRIs) in pregnancy relate to congenital anomalies, negative perinatal events and neurodevelopmental outcome. ...Areas covered: The possible interactions of SSRIs and serotonin and n …
Possible negative effects of selective serotonin reuptake inhibitors (SSRIs) in pregnancy relate to congenital anomalie …
Selective Serotonin Reuptake Inhibitors and Autism.
Walch TJ, Tinkelman A. Walch TJ, et al. Am J Ther. 2016 Mar-Apr;23(2):e325. doi: 10.1097/MJT.0000000000000441. Am J Ther. 2016. PMID: 26950585 No abstract available.
The Association Between Antenatal Exposure to Selective Serotonin Reuptake Inhibitors and Autism: A Systematic Review and Meta-Analysis.
Brown HK, Hussain-Shamsy N, Lunsky Y, Dennis CE, Vigod SN. Brown HK, et al. J Clin Psychiatry. 2017 Jan;78(1):e48-e58. doi: 10.4088/JCP.15r10194. J Clin Psychiatry. 2017. PMID: 28129495 Review.
OBJECTIVE: This systematic review and meta-analysis examines the relationship between antenatal selective serotonin reuptake inhibitor (SSRI) exposure and child autism, with specific attention to maternal mental illness (MMI) as a potential confounding factor …
OBJECTIVE: This systematic review and meta-analysis examines the relationship between antenatal selective serotonin reuptake i …
Autism spectrum disorder and prenatal exposure to selective serotonin reuptake inhibitors: A systematic review and meta-analysis.
Kobayashi T, Matsuyama T, Takeuchi M, Ito S. Kobayashi T, et al. Reprod Toxicol. 2016 Oct;65:170-178. doi: 10.1016/j.reprotox.2016.07.016. Epub 2016 Jul 26. Reprod Toxicol. 2016. PMID: 27474253 Review.
To obtain the risk estimates of autism spectrum disorder (ASD) in the offspring exposed to serotonin reuptake inhibitors (SSRI) in utero, we performed systematic review and meta-analysis of relevant studies. ...
To obtain the risk estimates of autism spectrum disorder (ASD) in the offspring exposed to serotonin reuptake
Pharmacotherapy for Perinatal Depression.
Lusskin SI, Khan SJ, Ernst C, Habib S, Fersh ME, Albertini ES. Lusskin SI, et al. Clin Obstet Gynecol. 2018 Sep;61(3):544-561. doi: 10.1097/GRF.0000000000000365. Clin Obstet Gynecol. 2018. PMID: 29561284 Review.
Although different studies have produced different results, the majority have not shown increases in risk for selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, tricyclic antidepressants, or the noradre …
Although different studies have produced different results, the majority have not shown increases in risk for selective serotonin
The use of memantine in neuropsychiatric disorders: An overview.
Lu S, Nasrallah HA. Lu S, et al. Ann Clin Psychiatry. 2018 Aug;30(3):234-248. Ann Clin Psychiatry. 2018. PMID: 30028898 Review.
RESULTS: Memantine monotherapy was found to exert efficacy in several neuropsychiatric conditions, including autism spectrum disorder, binge eating disorder, and attention-deficit/hyperactivity disorder. ...In obsessive-compulsive disorder (OCD) …
RESULTS: Memantine monotherapy was found to exert efficacy in several neuropsychiatric conditions, including autism spectrum disor
486 results
Jump to page
Feedback